Gastric Cancer
Copyright ©The Author(s) 2003.
World J Gastroenterol. Mar 15, 2003; 9(3): 427-431
Published online Mar 15, 2003. doi: 10.3748/wjg.v9.i3.427
Table 3 Relationship between the expression of hTRTmRNA, hTRT protein and clinicopathological parameters in gastric cancer
ParametersnhTRTmRNA positive (%)PhTRT protein positive(%)P
Gender
Male4235 (83.3)0.30939 (92.9)0.180
Female117(63.6)8 (72.7)
Age(years)
<552518 (72.0)0.21920 (80.0)0.147
≥ 552824 (85.7)27 (96.4)
Tumor size(cm)
< 52420 (83.3)0.73522 (91.7)0.678
≥ 52922 (75.9)25 (86.2)
Tumor location
Cardia2623 (88.5)0.12824 (92.3)0.529
Body1610 (62.5)13 (81.3)
Antrum119 (81.8)10 (90.9)
Lymph node metastasis
Absent2518 (72.0)0.21920 (80.0)0.089
Present2824 (85.7)27 (96.4)
Invasion depth
Not invading serosa87(87.5)0.8797 (87.5)1.000
Invading serosa4535 (77.8)40 (88.9)
Clinical stage
I and II4737 (78.7)1.00041 (87.2)0.806
III and IV65 (83.3)6 (100.0)